Business Context and Reporting Period
Company: IM Cannabis Corp.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2025 (Report No. 3)
Date of Filing: August 13, 2025
Headquarters: Kibbutz Glil Yam, Central District, Israel
This filing reports on the amendment of common share purchase warrants issued during a private placement that closed on November 12, 2024.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a warrant amendment and the filing of a resale registration statement.
Material Changes
On August 13, 2025, the Company entered into agreements to amend the terms of certain common share purchase warrants (the "Warrants") from the 2024 Private Placement. The material changes include:
- Exercise Price Reduction: Reduced from C$4.32 per common share to C$3.43 per common share.
- Expiration Date Extension: Extended from November 12, 2026, to July 31, 2030.
- Other Terms: All other terms of the Warrants remain unchanged.
Guidance, Outlook, and Management Commentary
The Company issued a press release on August 13, 2025, titled "IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing." The filing incorporates this report by reference into the Company's Registration Statements on Form F-3 (File Nos. 333-288346 and 333-289571). No specific financial guidance, risk factors, or contingencies are detailed within the text of this specific Form 6-K.
Investor Verification Checklist
- Verify the full text of the Form of Amendment to Common Warrant (Exhibit 99.2) for any conditions or covenants not summarized in the filing.
- Review the Form F-3 Resale Registration Statement (File No. 333-289571) to understand the implications of the warrant amendments on potential share dilution.
- Confirm the number of warrants affected by the amendment to assess the total potential impact on the share count.
- Check for any subsequent filings that may supersede the terms described in this August 13, 2025 report.